Clinical Trial

Nifedipine Extended-Release in Patients With Mild or Moderate Hypertension

Completed Phase 3
View on ClinicalTrials.gov →
Summary
To evaluate the efficacy of Nifedipine 30mg Extended-Release Richmond versus Nifedipine 30mg extended-release with a current registration in Colombia, measured by the proportion of patients with controlled blood pressure in adult patients diagnosed with mild or moderate hypertension at week 8 of follow-up.
Trial Details
NCT Number NCT07448506
Lead Sponsor Laboratorios Richmond S.A.C.I.F.
Collaborators: Laboratorios Richmond Colombia SAS
Conditions High Blood Pressure (& [Essential Hypertension])
Enrollment 50 participants
Start Date 2024-07-09
Primary Completion 2025-04-15 (estimated)
Study Completion 2025-08-13 (estimated)
Updated on ClinicalTrials.gov 2026-08-13